Supplementary materials for Article: Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of three clinical trials

Description

Supplementary materials for Article: Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of three clinical trials Authors: Amy S. Paller, MD, Elaine C. Siegfried, MD, Michael J Cork, BS, MB, PhD, FRCP, Kenji Kabashima, MD, PhD, Peter D. Arkwright, MD, PhD, Edyta Gębska, MD, PhD, Zhen Chen, PhD, Joseph Zahn, MD, Ana B. Rossi, MD, CMD Journal: Journal of the American Academy of Dermatology (JAAD) - Supplements - Plain Language Summary - Author narrated video abstract

Institutions

• Northwestern University Feinberg School of Medicine

  IL, Chicago

Categories

Funders

• Sanofi (United States)

  New Jersey, United States
• Regeneron (United States)

  New York, United States

Licence